Regional Health is involved in brain cancer research trials. Below is more information about the purpose and who the physician (principal investigator) is for each trial. For more in-depth information on the research studies, click the blue name which will lead you to the U.S. National Institute of Health website or call (605) 719-2300.
Phase III Intergroup Study of Radiotherapy vs Temozolomide Alone vs Radiotherapy with Concomitant and Adjuvant Temozolomide for Patient with 1p/19q Codeleted Anaplastic Glioma
|To learn more, contact:
John T. Vucurevich Cancer Care Institute
Michael Robinson, MD